Medial Border of Laparoscopic D3 Lymphadenectomy for Right Colon Cancer
NCT ID: NCT04518449
Last Updated: 2024-02-26
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
WITHDRAWN
OBSERVATIONAL
2022-12-01
2025-10-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Laparoscopic Right Hemicoloectomy for Right Colon Cancer With a Medial-to-lateral Approach Orientated by SMA or SMV
NCT03329495
Standardization of Laparoscopic Surgery for Right Hemi Colon Cancer (SLRC)
NCT02942238
Study on Laparoscopic Spleen-Preserving No. 10 Lymph Node Dissection for Advanced Middle or Upper Third Gastric Cancer
NCT02333721
Clinical Outcomes of Laparoscopic D1 Versus D2 Lymphadenectomy for Elderly Patients With Advanced Gastric Cancer
NCT03290209
Lateral Pelvic Lymph Node Dissection for Rectal Neuroendocrine Neoplasms Undergoing Laparoscopic Total Mesenteric Excision
NCT06279299
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
SMA group
the medial border along the left side of superior mesenteric artery (SMA)
medial border along the left side of SMA
to place the medial border along the left side of SMA in laparoscopic D3 lymphadenectomy for right colon cancer
SMV group
the medial border along the left side of superior mesenteric vein (SMV)
medial border along the left side of SMV
to place the medial border along the left side of SMV in laparoscopic D3 lymphadenectomy for right colon cancer
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
medial border along the left side of SMA
to place the medial border along the left side of SMA in laparoscopic D3 lymphadenectomy for right colon cancer
medial border along the left side of SMV
to place the medial border along the left side of SMV in laparoscopic D3 lymphadenectomy for right colon cancer
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* American Society of Anesthesiologists (ASA) score I to III
* A biopsy proven histological diagnosis of colorectal carcinoma
* tumor located at right half of colon
* Undergoing laparoscopic right hemi-colectomy
* preoperative staging cT2-4aN0M0 or cTanyN+M0
* willing to participate and informed consent signed
Exclusion Criteria
* Synchronous colorectal carcinoma
* History of colorectal cancer or other malignant tumors
* Clinical evidence of metastasis
* Preoperative staging cT1N0 or cT4bNany
* Emergency procedure
18 Years
75 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Shanghai Minimally Invasive Surgery Center
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Cai Zhenghao
Attending surgeon of gastrointestinal surgery，Ruijin Hospital, Shanghai Jiaotong University School of Medicine
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
MISC- Medial border of D3
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.